心脏磁共振T1 Mapping定量分析重度主动脉瓣反流心肌纤维化程度的价值

doi:10.3969/j.issn.1671-7171.2022.04.006

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1158 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要【目的】探讨心脏磁共振(CMR)纵向弛豫时间定量(T1 mapping)技术评估重度主动脉瓣反流(AR)心肌纤维化程度的价值。【方法】选择2018年1月至2020年11月在本院进行CMR成像检查的28例重度AR患者(观察组),选择同期在本院行CMR检查,未发现器质性心脏病者为对照组。比较两组左心室心肌质量(LVMM)、左心室舒张末期容积指数(LVEDVi)、左心室收缩末期容积指数(LVESVi)、左心室每搏输出量容积指数 (LVSVi)及左心室射血分数(LVEF)等结构、功能参数及心肌T1值、细胞外间质容积分数(ECV)值,并采用Pearson系数进行相关性分析。【结果】观察组LVEF低于对照组,LVEDVi、LVESVi、LVSVi、LVMM均高于对照组,差异有统计学意义(P<0.05)。延迟强化方面,观察组中有15例患者出现对比剂延迟增强(LGE),对照组中未发现LGE,组间差异有统计学意义(P<0.05)。左心室心肌纤维化方面,观察组初始T1值、ECV均高于对照组,增强后T1值低于对照组,差异有统计学意义(P<0.05)。Pearson相关系数分析显示,初始T1值、ECV值与LVEF呈负相关关系(r=－0.403、－0.400,均P<0.05);增强后T1值与LVEF无明显相关性(r=0.419,P=0.052>0.05)。【结论】CMR T1 mapping技术可反映重度AR患者心肌纤维化程度,且患者心肌纤维化程度与早期心脏重构和左心室收缩功能障碍相关。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

关键词 ：主动脉瓣关闭不全/影像诊断, 心肌, 纤维化, 磁共振成像

Abstract：【Objective】To explore the application value of T1 mapping quantified with cardiac MR (CMR) in the evaluation of left ventricular systolic function and myocardial fibrosis in severe aortic regurgitation (AR) patients. 【Methods】28 patients with severe AR in our hospital from January 2018 to November 2020 and 30 subjects at the same period for physical examination were selected as study group and control group respectively, and they were given cardiac magnetic resonance (CMR) and T1 mapping. The left ventricular myocardial mass (LVMM), left ventricular end diastolic volume index (LVEDVi), left ventricular end systolic volume index (LVESVi), left ventricular stroke volume index (LVSVi) , left ventricular ejection fraction (LVEF) , initial T1 value, enhanced T1 value and ECV value were compared between the two groups,and Pearson coefficient for correlation analysis. 【Results】 The LVMM, LVEDVi, LVESVi and LVSVi in study group were higher than those in control group (P<0.05); the LVEF in study group was lower than those in control group (P<0.05); the initial T1 value and ECV in study group were higher than those in control group (P<0.05); Pearson Correlation analysis showed that the initial T1 value and ECV value were negatively correlated with LVEF (P<0.05). 【Conclusion】T1 mapping can reflect the diffuse fibrosis of the myocardium in patients with severe AR, which is related to early cardiac remodeling and left ventricular systolic dysfunction to identify subclinical myocardial changes caused by volume overload before clinical symptoms appear.

Key words： Aortic Valve Insufficiency/DG Myocardium Fibrosis Magnetic Resonance Imaging

收稿日期: 2021-12-17

中图分类号:

R542.52

基金资助:深圳市卫生系统科研项目资助(编号:SZFZ2018017)

通讯作者: **E-mail:yxchmail@aliyun.com

引用本文:

李涯, 高立, 胡国迎, 聂伟霞, 蔡震宇, 袁旭春. 心脏磁共振T1 Mapping定量分析重度主动脉瓣反流心肌纤维化程度的价值[J]. 医学临床研究, 2022, 39(4): 500-502.
LI Ya, GAO Li, HU Guo-ying, et al. Cardiac Magnetic Resonance T1 Mapping Quantitative Analysis of Severe Aortic Regurgitation Myocardial Fibrosis. JOURNAL OF CLINICAL RESEARCH, 2022, 39(4): 500-502.

链接本文:

http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2022.04.006 或 http://journal07.magtech.org.cn/yxlcyj/CN/Y2022/V39/I4/500

[1] NISHIMURA R A. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the american college of cardiology/american heart association task force on practice guidelines[J].J Am Coll Cardiol,2014,63(22): 2438-2488.
[2] PODLESNIKAR T. Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease[J].Int J Cardiovasc Imaging,2018,34(1): 97-112.
[3] 陈秀玉, 赵世华. 2017 SCMR心脏磁共振参数定量技术专家共识解读[J].磁共振成像,2018,9(5): 368-373.
[4] AZEVEDO C F, NIGRI M, HIGUCHI M L, et al. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease[J].J Am Coll Cardiol,2010,56(4): 278-287.
[5] MESSROGHLI DANIEL R, MOON JAMES C, FERREIRA VANESSA M, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for cardiovascular magnetic resonance (SCMR) endorsed by the european association for cardiovascular imaging (EACVI)[J].J Cardiovasc Magn Reson,2017,19(1):75.
[6] NISHIMURA R A, OTTO C M, BONOW R O, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the american college of cardiology/american heart association task force on clinical practice guidelines[J].Circulation,2017,135(25): e1159-e1195.
[7] 孟庆江, 张双林, 郑先杰,等. DE-CMR在主动脉关闭不全患者手术预后评估中的应用分析[J].中国CT和MRI杂志,2017,15(8): 146-148.
[8] EDWARDS N C, MOODY W E, YUAN M, et al. Quantification of left ventricular interstitial fibrosis in asymptomatic chronic primary degenerative mitral regurgitation[J].Circ Cardiovasc Imaging,2014,7(6):946-953.
[9] ROBINSON A A, CHOW K, SALERNO M. Myocardial T1 and ECV Measurement: Underlying Concepts and Technical Considerations[J].JACC Cardiovasc Imaging,2019,12(11 Pt 2): 2332-2344.
[10] SPARROW P, MESSROGHLI D R, REID S,et al. Myocardial T1 mapping for detection of left ventricular myocardial fibrosis in chronic aortic regurgitation: pilot study[J].AJR Am J Roentgenol,2006,187(6): W630-635.
[11] DE MEESTER DE RAVENSTEIN C, BOUZIN C, LAZAM S, et al. Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3T[J].J Cardiovasc Magn Reson,2015,17(1):48.
[12] 郑育聪,陆敏杰,尹刚,等. 心血管MR T1 mapping/iECV定量分析在主动脉瓣关闭不全评价中的价值[J].中华血液学杂志,2021,55(3): 269-275.